标题
Therapies to Slow, Stop, or Reverse Parkinson’s Disease
作者
关键词
-
出版物
Journal of Parkinsons Disease
Volume 8, Issue s1, Pages S115-S121
出版商
IOS Press
发表日期
2018-12-19
DOI
10.3233/jpd-181481
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages
- (2018) Anetta Härtlova et al. EMBO JOURNAL
- The role of glucocerebrosidase in Parkinson disease pathogenesis
- (2018) Matthew E. Gegg et al. FEBS Journal
- Brain inflammatory cascade controlled by gut-derived molecules
- (2018) Hartmut Wekerle NATURE
- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
- (2018) Seung Pil Yun et al. NATURE MEDICINE
- Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease
- (2018) Donghoon Kim et al. Nature Nanotechnology
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
- (2018) Ken Y. Hui et al. Science Translational Medicine
- Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease
- (2018) Margaret Schenkman et al. JAMA Neurology
- Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
- (2018) J. Magalhaes et al. Scientific Reports
- Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection
- (2017) Viviane Labrie et al. Journal of Innate Immunity
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- New perspectives on study designs for evaluating neuroprotection in Parkinson's disease
- (2017) Laetitia Thibault et al. MOVEMENT DISORDERS
- T cells from patients with Parkinson’s disease recognize α-synuclein peptides
- (2017) David Sulzer et al. NATURE
- Parkinson disease: Defining PD subtypes — a step toward personalized management?
- (2017) Caroline H. Williams-Gray et al. Nature Reviews Neurology
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- Chronic, intermittent convection-enhanced delivery devices
- (2016) Owen Lewis et al. JOURNAL OF NEUROSCIENCE METHODS
- Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study
- (2016) Per Svenningsson et al. MOVEMENT DISORDERS
- Insulin resistance and Parkinson’s disease: A new target for disease modification?
- (2016) D. Athauda et al. PROGRESS IN NEUROBIOLOGY
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy
- (2016) Vinicius M. Fava et al. PLoS Neglected Tropical Diseases
- UDCA exerts beneficial effect on mitochondrial dysfunction inLRRK2G2019Scarriers and in vivo
- (2015) Heather Mortiboys et al. NEUROLOGY
- Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
- (2015) Reina N. Fuji et al. Science Translational Medicine
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
- (2014) Franziska Richter et al. Neurotherapeutics
- The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
- (2014) Senthilkumar S. Karuppagounder et al. Scientific Reports
- Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
- (2013) Heather Mortiboys et al. BRAIN
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
- (2013) Daniah Trabzuni et al. PLoS One
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- A comparative study of Lrrk2 function in primary neuronal cultures
- (2010) Justus C. Dächsel et al. PARKINSONISM & RELATED DISORDERS
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now